EPISODE · Aug 19, 2025 · 4 MIN
日本自闭症干细胞疗法上市!是希望还是豪赌?
from 天方烨谈
从实验室到临床,干细胞治疗为全球数千万自闭症家庭带来新希望。2025年8月11日,日本厚生劳动省正式批准了Biostar研究所的“天使干细胞疗法”用于自闭症谱系障碍(ASD)治疗。这是全球首个获得国家级药监部门批准的自闭症干细胞治疗方案,标志着再生医学在神经发育障碍领域取得重大突破。自闭症谱系障碍患者及其家庭,迎来了一个全新的治疗选择。
Embed this episode
NOW PLAYING
日本自闭症干细胞疗法上市!是希望还是豪赌?
0:00
4:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of 天方烨谈?
This episode is 4 minutes long.
When was this 天方烨谈 episode published?
This episode was published on August 19, 2025.
Can I download this 天方烨谈 episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!